In Oprah Winfrey’s newest television special Shame, Blame, and the Weight Loss Revolution, the celebrated television host tells the crowd that when she got over the excitement of first appearing on the cover of TV Guide, she noticed a demeaning headline referencing her weight. “Bumpy, lumpy, and downright dumpy,” the magazine read. That sentiment would be echoed in the hateful and rude treatment, Winfrey said, that has followed her throughout her career.
“I took on the shame that the world gave to me,” Winfrey, 70, said in her newest special.
“I took on the shame that the world gave to me,” Winfrey, 70, said in her newest special.
- 3/20/2024
- by CT Jones
- Rollingstone.com
Oprah Winfrey has set an hour-long ABC primetime special about weight loss drugs following her exit from the board of WeightWatchers after revealing her personal use of them. The special, titled “An Oprah Special: Shame, Blame and the Weight Loss Revolution,” will air later this month. Oprah recorded the special in front of a live studio audience and gathers medical experts to discuss weight loss drugs such as Ozempic, Mounjaro and Wegovy.
“It is a very personal topic for me and for the hundreds of millions of people impacted around the globe who have for years struggled with weight and obesity,” said Oprah in a statement. “This special will bring together medical experts, leaders in the space and people in the day-to-day struggle to talk about health equity and obesity with the intention to ultimately release the shame, judgment and stigma surrounding weight.”
Stream 'An Oprah Special' On Hulu
The...
“It is a very personal topic for me and for the hundreds of millions of people impacted around the globe who have for years struggled with weight and obesity,” said Oprah in a statement. “This special will bring together medical experts, leaders in the space and people in the day-to-day struggle to talk about health equity and obesity with the intention to ultimately release the shame, judgment and stigma surrounding weight.”
Stream 'An Oprah Special' On Hulu
The...
- 3/7/2024
- by Zack Sharf
- Variety Film + TV
Oprah Winfrey is taking on the weight-loss injectable trend in a new primetime special.
ABC announced “An Oprah Special: Shame, Blame and the Weight Loss Revolution,” with Winfrey hosting a sit-down conversation with medical experts and patients about “the radical impact” of prescription weight-loss medications like Ozempic, Mounjaro and Wegovy. The program will mark Winfrey’s first primetime special in three years.
“It is a very personal topic for me and for the hundreds of millions of people impacted around the globe who have for years struggled with weight and obesity,” Winfrey said in a statement. “This special will bring together medical experts, leaders in the space and people in the day-to-day struggle to talk about health equity and obesity with the intention to ultimately release the shame, judgment and stigma surrounding weight.”
Winfrey previously confirmed she was taking a weight-loss medication (without naming which) in December after appearing on...
ABC announced “An Oprah Special: Shame, Blame and the Weight Loss Revolution,” with Winfrey hosting a sit-down conversation with medical experts and patients about “the radical impact” of prescription weight-loss medications like Ozempic, Mounjaro and Wegovy. The program will mark Winfrey’s first primetime special in three years.
“It is a very personal topic for me and for the hundreds of millions of people impacted around the globe who have for years struggled with weight and obesity,” Winfrey said in a statement. “This special will bring together medical experts, leaders in the space and people in the day-to-day struggle to talk about health equity and obesity with the intention to ultimately release the shame, judgment and stigma surrounding weight.”
Winfrey previously confirmed she was taking a weight-loss medication (without naming which) in December after appearing on...
- 3/7/2024
- by James Hibberd
- The Hollywood Reporter - Movie News
Oprah Winfrey is stepping down from her role with WeightWatchers.
The 70-year-old media mogul announced plans to give up her spot on the company’s board after nearly a decade in the position. Her decision comes several months after she revealed that she’d been taking weight-loss medication.
She revealed what she’d be doing with her stocks and issued a statement about the decision.
Keep reading to find out more…
According to Variety, Oprah informed WeightWatchers‘ shareholders about her decision during a meeting this month.
When she joined the board in 2015, she owned a 10% stake in the company. She now owns approximately 1.4% of the company and plans to donate the stock to the National Museum of African American History and Culture.
Her remaining stocks are estimated to be worth less than $4 million.
“I look forward to continuing to advise and collaborate with WeightWatchers and CEO Sima Sistani in elevating...
The 70-year-old media mogul announced plans to give up her spot on the company’s board after nearly a decade in the position. Her decision comes several months after she revealed that she’d been taking weight-loss medication.
She revealed what she’d be doing with her stocks and issued a statement about the decision.
Keep reading to find out more…
According to Variety, Oprah informed WeightWatchers‘ shareholders about her decision during a meeting this month.
When she joined the board in 2015, she owned a 10% stake in the company. She now owns approximately 1.4% of the company and plans to donate the stock to the National Museum of African American History and Culture.
Her remaining stocks are estimated to be worth less than $4 million.
“I look forward to continuing to advise and collaborate with WeightWatchers and CEO Sima Sistani in elevating...
- 2/29/2024
- by Just Jared
- Just Jared
Oprah Winfrey is leaving the board of directors of WeightWatchers after a 9-year run and donating her stock in the company in order to avoid any potential conflict of interest over her use of weight-loss medication.
Shares in the company fell almost 20% on the news.
In addition to not standing for re-election in May when the company holds board elections, Winfrey said she plans to donate all of her stock in WW to the the National Museum of African American History and Culture. As of Jan. 1, she owned 1.13 million shares worth $6.34 million, according to data from Lseg.
The company said Winfrey is giving to the museum in order to support its goal to “promote and highlight the contributions of African Americans and to eliminate any perceived conflict of interest around her taking weight loss medications.” She will also donate the proceeds from any future exercises of her WW stock options to Nmaahc.
Shares in the company fell almost 20% on the news.
In addition to not standing for re-election in May when the company holds board elections, Winfrey said she plans to donate all of her stock in WW to the the National Museum of African American History and Culture. As of Jan. 1, she owned 1.13 million shares worth $6.34 million, according to data from Lseg.
The company said Winfrey is giving to the museum in order to support its goal to “promote and highlight the contributions of African Americans and to eliminate any perceived conflict of interest around her taking weight loss medications.” She will also donate the proceeds from any future exercises of her WW stock options to Nmaahc.
- 2/29/2024
- by Dade Hayes
- Deadline Film + TV
Oprah Winfrey is parting ways with WeightWatchers after nearly 10 years on the company’s board of directors.
The company says that Winfrey told the board this week that she would not stand for reelection at the company’s next annual meeting, set for May 9. Winfrey has been a board member and a public face for WeightWatchers since 2015.
The company says that Winfrey will still continue to work as a public advocate regarding weight health and obesity issues, including co-hosting an event together in May. It also says that Winfrey will donate all her shares in the company to the National Museum of African American History and Culture.
“Ms. Winfrey is making the donation to support the Nmaahc’s goal to promote and highlight the contributions of African Americans and to eliminate any perceived conflict of interest around her taking weight loss medications,” the company said in a statement, suggesting that...
The company says that Winfrey told the board this week that she would not stand for reelection at the company’s next annual meeting, set for May 9. Winfrey has been a board member and a public face for WeightWatchers since 2015.
The company says that Winfrey will still continue to work as a public advocate regarding weight health and obesity issues, including co-hosting an event together in May. It also says that Winfrey will donate all her shares in the company to the National Museum of African American History and Culture.
“Ms. Winfrey is making the donation to support the Nmaahc’s goal to promote and highlight the contributions of African Americans and to eliminate any perceived conflict of interest around her taking weight loss medications,” the company said in a statement, suggesting that...
- 2/29/2024
- by Alex Weprin
- The Hollywood Reporter - Movie News
Since Ozempic first went from drug newcomer to viral superstar, the semaglutide injectable has been hailed as an advancement for pharmaceutical brands, wellness treatments, telehealth companies, endocrinologist plans, bariatric therapy, and most major health-related enterprises. Now, the weight loss industry wants in.
In March, popular weight loss program WeightWatchers acquired telehealth platform Sequence and announced members would be able to use the new subscription-based acquisition to get Glp-1 weight loss medications like Ozempic, Wegovy, and tablet options like Rybelsus. But the move seems to be at odds with the longstanding tenets of the program.
In March, popular weight loss program WeightWatchers acquired telehealth platform Sequence and announced members would be able to use the new subscription-based acquisition to get Glp-1 weight loss medications like Ozempic, Wegovy, and tablet options like Rybelsus. But the move seems to be at odds with the longstanding tenets of the program.
- 7/30/2023
- by CT Jones
- Rollingstone.com
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.